Donatello Crocetta

Global Head of Medical Affairs and Chief Medical Officer at UCB

Appears in 1 story

Stories

FDA approves Zilbrysq autoinjector for daily self-injection in generalized myasthenia gravis

Leads global medical affairs for UCB

Adults with generalized myasthenia gravis can now take their daily Zilbrysq dose with a spring-loaded autoinjector, not just a prefilled syringe. The FDA cleared the device on October 16, after data showed 90% of first-time users completed an injection without any training.

Updated 3 hours ago